This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Impact of Treatment Induced Premature Menopause on Quality of Life

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT00185718
First received: September 12, 2005
Last updated: December 12, 2012
Last verified: December 2012
  Purpose
To understand the impact of treatment induced menopause on quality of life and sexuality following blood and marrow transplantation.

Condition
Menopause, Premature

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Impact of Treatment Induced Premature Menopause on Quality of Life Following Blood and Marrow Transplantation

Resource links provided by NLM:


Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Quality of life [ Time Frame: 1 year ]
    To describe the impact of premature menopause on sexuality and quality of life.

  • Sexuality [ Time Frame: 1 year ]
    To describe the impact of premature menopause on sexuality and quality of life.


Enrollment: 97
Study Start Date: November 2003
Study Completion Date: September 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women become menopausal as a result of BMT
Criteria

Inclusion Criteria:

  • premenopausal
  • sexually active women
  • able to read and write English

Exclusion Criteria:

- postmenopausal females

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00185718

Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Karl G. Blume Stanford University
  More Information

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT00185718     History of Changes
Other Study ID Numbers: BMT160
79700
13644 ( Other Identifier: Stanford IRB )
Study First Received: September 12, 2005
Last Updated: December 12, 2012

Additional relevant MeSH terms:
Premature Birth
Menopause, Premature
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female

ClinicalTrials.gov processed this record on June 23, 2017